NovoCure (NASDAQ: NVCR)
NovoCure Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NovoCure Company Info
Novocure's tumor-treating field devices use electric fields to disrupt the replication of cancer cells.
News & Analysis
Why NovoCure Stock Skyrocketed This Week
Why NovoCure Stock Leaped 4% Higher Today
NovoCure Surpasses Q1 Expectations
NovoCure posted stronger-than-expected Q1 2025 results, driven by revenue and GAAP earnings surpassing estimates.
Why NovoCure Stock Was Withering on Wednesday
Prediction: Novocure (NVCR) Will Beat the Market. Here's Why
NovoCure Q4 EPS Misses, Revenue Matches
NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.
Why NovoCure Stock Was Winning Big This Week
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?
Valuation
Podcast Episodes
Why NovoCure's Regulatory News Is a Huge Win for Investors
The cancer-focused medical-device maker received the go-ahead to enter a brand-new market. Here's why the news should make investors giddy.
2 Winners and 2 Losers in the Med Tech Market This Quarter
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
3 Medical Device Companies for Your Watchlist
Recurring revenue, monopolistic market positions, and returns that tend to beat even the risky biotechs tie these three together.
Earnings Transcripts
NovoCure (NVCR) Q4 2024 Earnings Call Transcript
NVCR earnings call for the period ending December 31, 2024.
NovoCure (NVCR) Q3 2024 Earnings Call Transcript
NVCR earnings call for the period ending September 30, 2024.
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
NVCR earnings call for the period ending June 30, 2024.
NovoCure (NVCR) Q1 2024 Earnings Call Transcript
NVCR earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.